Breaking the Silence: Why Pharma Needs to Speak Up with Brian Reid

🎙️ Real Pharma – Episode Title: Breaking the Silence: Why Pharma Needs to Speak UpHosts: Na-Ri Oh & Ian WendtGuest: Brian Reid, Founder & Principal at Reid Strategic

🔍 Episode Summary:

In this episode of Real Pharma, Na-Ri and Ian sit down with Brian Reid—a healthcare communicator, strategist, and former journalist who's worked across government, pharma, and media—to explore a provocative question: Why is the pharmaceutical industry so quiet when it comes to telling its own story?

Together, they unpack the communication failures shaping drug pricing, PBMs, the Inflation Reduction Act (IRA), biosimilars, and the broader healthcare system. Brian argues that the problem isn’t a lack of data or platforms—it’s a lack of courage, clarity, and commitment to narrative.

From the importance of speaking up in a noisy media environment to the myth of reputational risk, this conversation is a must-listen for anyone in life sciences, policy, or healthcare storytelling.

🧠 What You’ll Learn:

Why pharma’s “default to silence” is damaging public trust—and what the industry can do instead

The communications trap around complex topics like PBMs, pricing, and benefit design

How public perception problems could have been avoided with smarter storytelling (hello, Hep C)

Why simplicity is power—and how “pharm-to-table” and Mark Cuban are reframing the narrative

The case for overcommunication in the face of misinformation and AI-driven “slop”

Why the Medicare Prescription Payment Plan was a missed communication opportunity—and how to fix it